Source: ERS Lung Science Conference 2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Pien Goldsteen (Groningen, Netherlands). YI404 - Pluripotent stem cell derived airway cholinergic neurons for disease modelling of neuroplasticity in asthma. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Pluripotent stem cell derived airway cholinergic neurons for disease modelling of neuroplasticity in asthma Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Embryonic stem cells generate airway epithelium Source: Eur Respir J 2004; 24: Suppl. 48, 436s Year: 2004 Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Mesenchymal stem cells down-regulate inflammation but not airway hyperresponsiveness in experimental asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 3D models of human lung development and disease using pluripotent stem cells Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 The role of bone-marrow derived adult stem cells in asthmatic airway remodeling Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Upregulation of GABAergic system in human bronchial epithelial cells in severe asthma Source: Annual Congress 2009 - Translational models of lung disease Year: 2009 iPSC derived lung stem cells as tools to understand lung regeneration and disease Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Derivation of epithelial-only airway organoids from human pluripotent stem cells Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017